Antimicrobial Resistance and Infection Control · 2020 · 19 citations · 18 references
Life SciencesInfectious DiseasesMicrobiologyInfectious Disease EpidemiologyMedical MicrobiologyMycologyAntifungal TherapyFungal InfectionsHealthcare-associated Infection PreventionHealthcare-associated InfectionsInfection ManagementNosocomial Infection EpidemiologyCandida Albicans InfectionCandida DetectionFungal Infection Surveillance
To identify the prevalence of C. auris in Canadian patients who are potentially at risk for colonization, we screened 488 patients who were either hospitalized abroad, had a carbapenemase-producing organism (CPO), or were in units with high antifungal use. Two patients were colonized with C. auris; both had received healthcare in India and had a CPO. Among 35 patients who had recently received healthcare in the Indian subcontinent and were CPO colonized or infected, the prevalence of C. auris was 5.7%.
18
Shawn R. Lockhart, Kizee A. Etienne, Snigdha Vallabhaneni et al. · Clinical Infectious Diseases · 2016 · 1.6K citations · Full text
Rory M. Welsh, Meghan L. Bentz, Alicia M. Shams et al. · Journal of Clinical Microbiology · 2017 · 491 citations · Full text